Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Champions Oncology (CSBR) Income from Continuing Operations (2016 - 2026)

Champions Oncology (CSBR) has 16 years of Income from Continuing Operations data on record, last reported at 237000.0 in Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 67.45% year-over-year to 237000.0; the TTM value through Oct 2025 reached 2431000.0, up 506.52%, while the annual FY2025 figure was 4701000.0, 164.61% up from the prior year.
  • Income from Continuing Operations reached 237000.0 in Q4 2025 per CSBR's latest filing, up from 466000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 4495000.0 in Q1 2025 and bottomed at 2566000.0 in Q3 2023.
  • Average Income from Continuing Operations over 5 years is 354300.0, with a median of 245500.0 recorded in 2021.
  • Peak YoY movement for Income from Continuing Operations: skyrocketed 27600.0% in 2021, then crashed 12843.75% in 2023.
  • A 5-year view of Income from Continuing Operations shows it stood at 277000.0 in 2021, then crashed by 105.78% to 16000.0 in 2022, then plummeted by 12843.75% to 2071000.0 in 2023, then soared by 135.15% to 728000.0 in 2024, then crashed by 67.45% to 237000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Income from Continuing Operations were 237000.0 in Q4 2025, 466000.0 in Q3 2025, and 1835000.0 in Q2 2025.